Rottinghaus Scott T.
SEC insider (Form 3/4/5 filer). CIK 0001942407. Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA). 11 reported Form 4/5 transactions since Sep 2024; latest on Aug 8, 2026. Located in WATERTOWN, MA.
Companies Rottinghaus Scott T. has filed insider reports for
- ENANTA PHARMACEUTICALS INC (ENTA): Officer, Chief Medical Officer
Rottinghaus Scott T.
CIK: 0001942407
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENANTA PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Aug 8, 2026ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect1.5K shares at avg. $13.34$20K - Feb 12, 2026ENTA
ENANTA PHARMACEUTICALS INC
AwardDirect1.7K shares- - Feb 12, 2026ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect3.4K shares at avg. $14.25$49K - Feb 12, 2026ENTA
ENANTA PHARMACEUTICALS INC
AwardDirect5.2K shares- - Dec 5, 2025ENTA
ENANTA PHARMACEUTICALS INC
SaleDirect798 shares at avg. $14.23$11K - Nov 25, 2025ENTA
ENANTA PHARMACEUTICALS INC
AwardDirectStock Option (right to buy)
110K shares- - Aug 8, 2025ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect2.2K shares at avg. $6.99$15K - Feb 12, 2025ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect2.9K shares at avg. $5.59$16K - Feb 12, 2025ENTA
ENANTA PHARMACEUTICALS INC
AwardDirect9.8K shares- - Dec 6, 2024ENTA
ENANTA PHARMACEUTICALS INC
SaleDirect866 shares at avg. $8.06$7K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 8, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 1,467 | $13.34 | $19,570 | Direct |
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Award | 1,650 | - | $0 | Direct |
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 3,413 | $14.25 | $48,635 | Direct |
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Award | 5,225 | - | $0 | Direct |
| Dec 5, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Sale | 798 | $14.23 | $11,356 | Direct |
| Nov 25, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Award Stock Option (right to buy) | 110,000 | - | - | Direct |
| Aug 8, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 2,217 | $6.99 | $15,497 | Direct |
| Feb 12, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 2,861 | $5.59 | $15,993 | Direct |
| Feb 12, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Award | 9,750 | - | - | Direct |
| Dec 6, 2024 | ENTA ENANTA PHARMACEUTICALS INC | Sale | 866 | $8.06 | $6,980 | Direct |
1-10 of 11 transactions